Clinical Trial Update: A Study to Evaluate the Safety of Dostarlimab in Adult Participants in India With Recurrent or Advanced Endometrial Cancer (EC) [Phase 4]

View source ↗

Summary

This Phase 4 clinical trial update describes a study to evaluate the safety of dostarlimab in adults with recurrent or advanced endometrial cancer in India. The…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Endometrial Cancer

Drugs mentioned

• Dostarlimab (dostarlimab)

Snippet

Sponsor: GlaxoSmithKline | Conditions: Neoplasms, Endometrial | Phase 4 | Status: NOT_YET_RECRUITING